Collections:
Other Resources:
DOI: 10.1182/blood.2021014689
Paper Summary:
Title: Asciminib: new therapeutic option in chronic phase CML with treatment failure.
Author(s): Yeung, David T; Shanmuganathan, Naranie; Hughes, Timothy P
Year: 2022
DOI: 10.1182/blood.2021014689
URL: https://doi.org/10.1182/blood.2021014689
Received on: 2022-10-26
✍: FYIcenter.com
2022-10-26, ∼1188👍, 0💬
Related Topics:
Popular Posts:
Paper Summary: Title: Topical Capsaicin for the Treatment of Neuropathic Pain Author(s): Sultana, Ad...
Paper Summary: Title: Recruiting for Uncle Sam: Citizenship and Military Manpower Policy.by David R....
How to retrieve a list of DOIs with api.datacite.org/dois? If you want to retrieve a list of DOIs yo...
Paper Summary: Title: Schatzberg’s Manual of Psychopharmacology Author(s): Schatzberg, Alan F. ;DeBa...
Paper Summary: Title: Aboriginal Woman: Male and Female Anthropological Perspectives Author(s): ROHR...
